Last reviewed · How we verify
Megaloblastic anemia
Approved treatments
- Wellcovorin · Pfizer Japan Inc
- Fusilev · Spectrum Pharms
- Fusilev · Acrotech Biopharma
Fusilev works by bypassing the enzyme dihydrofolate reductase, allowing normal cell growth and DNA synthesis.
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Megaloblastic anemia patent landscape — cliff calendar, originator estates, attackable patents
- Megaloblastic anemia treatment landscape brief
- Megaloblastic anemia treatment updates RSS
Frequently asked questions about Megaloblastic anemia
What drugs treat Megaloblastic anemia?
Tracked treatments include Wellcovorin, Fusilev.
What is the treatment for Megaloblastic anemia?
Standard treatment for Megaloblastic anemia includes Wellcovorin, Fusilev. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Megaloblastic anemia patent cliff · Megaloblastic anemia CI report
- Treatment: Wellcovorin · Pfizer Japan Inc
- Treatment: Fusilev · Spectrum Pharms
- Treatment: Fusilev · Acrotech Biopharma
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing